Review
Nature Reviews Drug Discovery 1, 122-130 (February 2002) | doi:10.1038/nrd723
The potential for novel anti-inflammatory therapies for coronary artery disease
Margaret A. Cascieri1 About the author
Abstract
Although drugs that lead to cholesterol and lipid lowering have proved to have significant effects in lowering cardiovascular morbidity and mortality, coronary artery disease remains a principal cause of death worldwide. There is a clear need to discover further therapeutic approaches to control this disease adequately. This review focuses on the mechanisms that have been implicated in the recruitment, activation and differentiation of inflammatory monocytes/macrophages in nascent vascular lesions into lipid-laden foam cells. These mechanisms might provide attractive targets for novel therapies for coronary artery disease.
- View At a Glance
Author affiliations
-
Merck Research Laboratories, PO Box 2000, Rahway, New Jersey 07065, USA.
Email: pegcascieri@aol.com
|
MORE ARTICLES LIKE THIS These links to content published by NPG are automatically generated REFERENCE NEWS AND VIEWS RESEARCH |
